For research use only. Not for therapeutic Use.
BAY 2965501（Cat No.:I041293）is an investigational drug developed by Bayer, designed to target and inhibit specific enzymes involved in the regulation of inflammation and immune responses. It holds potential in treating inflammatory diseases, such as rheumatoid arthritis and other autoimmune conditions, by suppressing the underlying immune system dysfunction that causes excessive inflammation. Preclinical studies suggest that BAY 2965501 could offer a more effective treatment with fewer side effects compared to current therapies. Its mechanism of action aims to restore immune balance, reducing disease symptoms and improving patient outcomes.
| CAS Number | 2732902-08-6 |
| Synonyms | (2R)-2-(N-[4-amino-5-(4-methoxybenzoyl)-1,3-thiazol-2-yl]-4-fluoroanilino)propanamide |
| Molecular Formula | C20H19FN4O3S |
| Purity | ≥95% |
| IUPAC Name | (2R)-2-(N-[4-amino-5-(4-methoxybenzoyl)-1,3-thiazol-2-yl]-4-fluoroanilino)propanamide |
| InChI | InChI=1S/C20H19FN4O3S/c1-11(19(23)27)25(14-7-5-13(21)6-8-14)20-24-18(22)17(29-20)16(26)12-3-9-15(28-2)10-4-12/h3-11H,22H2,1-2H3,(H2,23,27)/t11-/m1/s1 |
| InChIKey | HSBUVKDEUUJREZ-LLVKDONJSA-N |
| SMILES | C[C@H](C(=O)N)N(C1=CC=C(C=C1)F)C2=NC(=C(S2)C(=O)C3=CC=C(C=C3)OC)N |
